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CONSPECTUS: Cellular structural biology methods are
needed to characterize biological processes at atomic
resolution in the physiological environment of the cell.
Toward this goal, solution in-cell NMR is a powerful approach
because it provides structural and dynamic data on macro-
molecules inside living cells. Several approaches have been
developed for in-cell NMR in cultured human cells, which are
needed to study processes related to human diseases that rely
on the delivery of exogenous macromolecules to the cells. Such
strategies, however, may not be applicable to proteins that are sensitive to the external environment or prone to aggregate and
can introduce artifacts during protein purification or delivery.
As a complementary approach, direct protein expression for in-cell NMR in human cells was developed. This strategy is
especially useful when studying processes like protein folding, maturation, and post-translational modification, starting right after
protein synthesis. Compared with the protein expression techniques in mammalian cells commonly used in cellular biology, the
low sensitivity of NMR requires higher protein levels. Among the cell lines used for high-yield protein expression, the HEK293T
cell line was chosen, as it can be efficiently transfected with a cost-effective reagent. A vector originally designed for secreted
proteins allows high-level cytosolic protein expression. For isotopic labeling, commercially available or homemade labeled media
are employed. Uniform or amino acid type-selective labeling strategies are possible. Protein expression can be targeted to specific
organelles (e.g., mitochondria), allowing for in organello NMR applications. A variant of the approach was developed that allows
the sequential expression of two or more proteins, with only one selectively labeled.
Protein expression in HEK293T cells was applied to recapitulate the maturation steps of intracellular superoxide dismutase 1
(SOD1) and to study the effect of mutations linked to familial amyotrophic lateral sclerosis (fALS) by in-cell NMR. Intracellular
wild-type SOD1 spontaneously binds zinc, while it needs the copper chaperone for superoxide dismutase (CCS) for copper
delivery and disulfide bond formation. Some fALS-linked mutations impair zinc binding and cause SOD1 to irreversibly unfold,
likely forming the precursor of cytotoxic aggregates. The SOD-like domain of CCS acts as a molecular chaperone toward mutant
SOD1, stabilizing its folding and allowing zinc binding and correct maturation. Changes in protein redox state distributions can
also be investigated by in-cell NMR. Mitochondrial proteins require the redox-regulating partners glutaredoxin 1 (Grx1) and
thioredoxin (Trx) to remain in the reduced, import-competent state in the cytosol, whereas SOD1 requires CCS for disulfide
bond formation. In both cases, the proteins do not equilibrate with the cytosolic redox pool. Cysteine oxidation in response to
oxidative stress can also be monitored.
In the near future, in-cell NMR in human cells will likely benefit from technological advancements in NMR hardware, the
development of bioreactor systems for increased sample lifetime, the application of paramagnetic NMR to obtain structural
restraints, and advanced tools for genome engineering and should be increasingly integrated with advanced cellular imaging
techniques.
■ INTRODUCTION
Understanding biological processes requires a complete
description of all of the involved molecules and their
interactions at atomic resolution. The atomistic description of
such processes is especially critical to develop novel chemicals
and therapeutic protocols against human diseases. While this
has always been the ultimate goal of structural biology, the
classical approaches require each biomolecule to be isolated and
analyzed far from its physiological context. Indeed, structural
characterization is mainly performed by X-ray diffraction on
crystalline solids at cryogenic temperatures, whereas a minor
fraction is performed by NMR spectroscopy on purified
molecules in solution at room temperature and, recently, on
vitrified samples by cryo-electron microscopy (cryo-EM). None
of these environments comes even close to the actual
physiological environment. In the last few decades, there have
been increasing efforts to integrate data from classical
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biochemistry, structural biology, and advanced cellular biology
techniques (e.g., super-resolved microscopy) in order to build a
more complete picture of the studied systems. However, such
reductionist approaches are challenged by the need to make
assumptions when working in vitro that may not be satisfied in
vivo, while on the other hand the in vivo or in cellulo analysis is
limited by the lack of atomic resolution. To overcome these
limitations, cellular structural biology methods that would allow
an atomistic description while preserving the physiological
environment of the investigated system are being increasingly
sought. In this context, NMR spectroscopy is the technique of
choice, as it is nondestructive, works at physiological temper-
atures, and can monitor time-dependent phenomena on
multiple time scales.
The first observation of an isotope-labeled protein by NMR
in living bacterial cells marked the birth of an approach aptly
named “in-cell NMR”.1,2 Clearly, observing macromolecules
such as proteins in human cells is of critical importance when
studying processes related to human diseases. Therefore, after
some initial developments and applications in bacteria,3 the
approach was extended to Xenopus laevis oocytes,4 the first
eukaryotic model, and was eventually applied to observe a
protein in human cells.5 That achievement provided a glimpse
of the true potential of in-cell NMR and sparked the interest of
the scientific community. In that work, proteins fused to the
HIV-1 Tat cell-penetrating peptide were expressed in bacteria,
purified, and subsequently delivered to the human cells by
exploiting the mechanism of the viral peptide. Later, other
approaches were developed for in-cell NMR and electron
paramagnetic resonance (EPR) in human cells, all of which
relied on alternative methods to deliver exogenous proteins,
specifically treatment of the cells with the pore-forming toxin
streptolysin O6 or permeabilization of the plasma membrane
through hypotonic swelling7 or electroporation.8 These
approaches have proven useful for observing intracellular
protein5−9 and DNA10 signals in human cells. However, their
application is often hampered by practical limitations, namely,
the high concentration of external protein needed to obtain
sufficiently high intracellular levels and the need to optimize the
insertion technique to increase the internalization efficiency,
which is highly dependent on the physicochemical properties of
the investigated proteins. Furthermore, the insertion of human
proteins purified from bacteria can introduce artifacts due to
chemical modifications (or lack thereof) occurring in bacteria
or during purification, resulting in nonphysiological cofactor
binding and/or redox states.
■ PROTEIN EXPRESSION IN HUMAN CELLS
The drawbacks of the protein insertion approaches are
especially critical when monitoring some cellular processes,
such as protein folding and maturation, cofactor binding, and
changes in redox states, where the physiological relevance of
the results requires each step to occur in the correct cellular
environment, starting from protein synthesis. For these
applications, the investigated proteins need to be expressed
directly in the physiologically relevant host cells. While
approaches for protein expression inside the cells analyzed by
in-cell NMR were developed in yeast11 and insect cells,12 an
approach relying on protein expression in human cells was
missing, which would have been a step forward in the ability to
study proteins related to human diseases in an environment as
close as possible to the native cellular environment. In an effort
to fill this gap and to further expand the range of applicability of
in-cell NMR, our lab developed a method to express isotope-
labeled proteins in human cells at levels suitable for NMR
detection (Figure 1).13,14 Protein overexpression in mammalian
cells is commonly used in cell biology, but the expression levels
required for detection via Western blot or fluorescence
microscopy are much lower than those needed for NMR. In
the last few decades, several mammalian cell lines suitable for
high-yield protein expression have been increasingly used both
by the pharmaceutical industry for the production of
biotherapeutic proteins and by scientists and biotech companies
as a way to obtain challenging proteins. Seeking a cellular
environment that would be as close to the native one as
possible for studying human proteins, we focused on a human
cell line, specifically the human embryonic kidney 293T
(HEK293T) cell line.15 The method that we developed is
based on an existing application of recombinant protein
expression in HEK293T cells originally developed for the
production of secreted glycosylated proteins for X-ray
crystallography.16 In that work, transient transfection of
adherent HEK293T cells was performed using branched
polyethylenimine (PEI), a cationic polymer, as a cost-effective
transfection reagent.17 PEI-mediated transfection ensures that
high gene copy numbers are internalized in HEK293T cells
with low toxicity. High-level protein expression is allowed by
the pHLsec vector, which contains a strong constitutive
synthetic promoter (CAG)18 followed by a secretion signal
Figure 1. Protein expression in human cells for in-cell NMR. (a) HEK293T cells are seeded in a culture flask and grown in unlabeled medium. (b)
The vector containing a gene of interest (green arrow) is delivered by transient transfection in labeled medium. (c) Protein expression is carried out
in labeled medium. (d) Cells expressing the protein of interest (green) are collected and placed in a 3 mm Shigemi NMR tube for in-cell NMR
analysis.
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sequence fused to the cDNA encoding the protein of interest.16
Because in-cell NMR aims to observe intracellular proteins, the
secretion signal is removed from the original vector so that the
protein of interest localizes in the cytoplasm. In the
investigation of proteins by in-cell NMR, isotopic labeling is
critical for two reasons: it allows heteronuclear multidimen-
sional NMR experiments and acts as a filter to remove signals
from the rest of the cell, so that only the labeled molecules are
detected. In our protocol, isotopic labeling is performed by
replacing the normal growth medium with an isotope-enriched
one at the time of transfection. Commercially available media
have been developed for uniform 15N or 13C,15N labeling in
mammalian cells.19 Uniform labeling can also be achieved using
custom-made media, e.g., those obtained from labeled algal
autolysates.20 Alternatively, amino acid type-selective labeling
strategies are possible for certain amino acids, such as
[15N]cysteine and [methyl-13C]methionine.13,14 During protein
expression phase in labeled media, other cellular components
are partially labeled, resulting in the presence of cellular
background signals in the NMR spectra. These background
signals can be greatly reduced by subtracting NMR spectra
acquired on a control sample of cells transfected with an empty
vector, where protein expression did not occur.14 As is
commonly the case with ectopic expression, this approach
results in the cytosolic localization of the protein of interest and
thus is best suited to investigate processes naturally occurring in
this cellular compartment. Notably, cytosolic localization can
also occur with proteins that are natively targeted to other
compartments, such as mitochondrial proteins, likely because of
the low efficiency of the native targeting sequence.21 However,
we showed that fusion with a more efficient targeting sequence
can effectively target the protein to the desired cellular
compartment.22 In that work, a mitochondrial targeting
sequence was used to target proteins in the mitochondrial
intermembrane space (IMS). Intact mitochondria containing
IMS-targeted labeled proteins were then isolated from
HEK293T cells, and the protein signals could be detected in
the resulting “in-mitochondria” NMR spectra. Therefore, in
principle this approach can allow other in organello NMR
studies to be performed by employing suitable targeting signals
for different cellular compartments. The high gene copy
number ensured by the employed transfection protocol allows
two or more genes to be cotransfected, so that the encoded
proteins are simultaneously expressed in the cells. However, for
proper characterization of protein−protein interactions by
NMR, only one protein at a time should be labeled. For in-cell
NMR purposes, this can be achieved by controlling the timing
of expression so that the proteins are sequentially expressed and
can be selectively labeled by appropriately switching the
expression medium. This was achieved previously in bacteria
by using expression vectors that could be independently
induced.23 For in-cell NMR in human cells, a sequential
expression approach was developed in which a first gene is
stably integrated into the host cell genome using an existing
workflow.24,25 The obtained stable cell line is then
cotransfected with the second gene and a mixture of vectors
encoding small hairpin RNAs against the first gene. By
appropriate timing of the incubation with labeled medium,
only the second protein is selectively labeled while both
proteins are present in the cells, allowing in principle the study
of protein−protein interactions by NMR. To date, the direct
expression approach for in-cell NMR has proven to be a
versatile alternative to protein insertion, as shown already in
other cellular systems.11,12 In human cells, several soluble
proteins could be expressed at levels ranging from ∼10 to ∼150
μM,14 which are sufficient for NMR detection provided that the
proteins do not interact diffusely with other cellular
components, causing excessive line broadening (a general
limitation of solution in-cell NMR that is partly resolvable by
introducing mutations on the protein surface26). The approach
has been applied to observe protein maturation and regulation
processes, which are outlined below.
■ APPLICATIONS
Folding and Maturation of Superoxide Dismutase 1
Protein expression in human cells was first applied by our lab to
investigate the folding and maturation pathway of wild-type
(WT) human copper, zinc superoxide dismutase 1 (SOD1) by
in-cell NMR.13 SOD1 is an evolutionarily conserved anti-
oxidant enzyme that is present in most tissues at relatively high
concentration, particularly in neuronal cells, and is localized in
the cytoplasm, nucleus, and mitochondria. In order to reach the
enzymatically active form, SOD1 needs to dimerize, bind one
zinc ion and one copper ion per monomer, and form an
intramolecular disulfide bond. In vivo, the latter two steps are
catalyzed by the specific partner copper chaperone for
superoxide dismutase (CCS).27,28 All of these events contribute
Figure 2. 1H−15N NMR spectra of different SOD1 maturation states in human cells. (a) With a defect of zinc, SOD1 (green) is mostly in the apo,
reduced state. (b) With zinc in excess, SOD1 dimerizes and binds one zinc ion (cyan) per monomer. (c) When CCS is coexpressed with zinc and
copper in excess (salmon), the fully mature, disulfide-oxidized copper,zinc-SOD1 is formed. Also see ref 13.
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to increasing the stability of the mature protein. SOD1 has been
linked to the onset of amyotrophic lateral sclerosis (ALS), a
degenerative disease characterized by the death of motor
neurons in the brain and spinal cord.29 To date, more than 180
mutations scattered throughout the protein have been
correlated to the onset of about 20% of familial ALS (fALS)
cases.30 Most mutations do not affect the enzymatic activity of
the mature protein; instead, they have detrimental effects on
various steps of the SOD1 maturation process through a toxic
gain of function. As a consequence of impaired maturation,
mutant SOD1 is less stable and more prone to misfold and
eventually to form aggregates, which are a hallmark of the
disease. The sequence of events leading to fully mature WT
SOD1 was recapitulated by NMR in human cells by treating
cells with different amounts of metal cofactors. With a defect of
zinc, the majority of SOD1 is in the monomeric, partially
unfolded apo state, with all of the cysteines in the reduced state
(Figure 2a). With an excess of zinc, binding to the apo protein
occurs spontaneously and quantitatively, and a zinc-bound
dimeric reduced species is formed (Figure 2b). Unlike in vitro,
a non-native form of SOD1 with a second zinc ion per
monomer bound to the copper site is not observed in the cells,
even with an excess of zinc. The higher selectivity exhibited in
the cell is likely a consequence of the cellular zinc homeostasis.
Intracellular copper is even more strictly regulated than zinc
and has to be delivered to SOD1 by the metallochaperone
CCS. Consistently, when copper is supplemented to the cells, it
is bound only by a small fraction of SOD1, delivered either by
means of the endogenous CCS, which cannot compensate for
the higher levels of SOD1, or by a CCS-independent
maturation pathway that has been reported for human
SOD1.31 Cotransfection of both SOD1 and CCS cDNAs
compensates for the increased levels of SOD1: upon copper
treatment in the presence of higher levels of CCS, both copper
binding and disulfide bond formation occur, and the mature
form of SOD1 is observed (Figure 2c). Interestingly, CCS
coexpression promotes the SOD1 disulfide bond formation also
in the absence of copper, indicating that the metal transfer and
redox reaction can be uncoupled in vivo under certain
circumstances.
Given the importance of the SOD1 maturation pathway in
the pathogenesis of fALS, we also investigated it for a set of
fALS-linked SOD1 mutants.32 We focused on WT-like
mutations, which do not perturb the metal binding sites of
the protein or reduce the activity of the mature enzyme.
Strikingly, a subset of the investigated SOD1 mutants failed to
bind zinc in the cell even when zinc was available in excess and
accumulated in the cytosol as unfolded species (Figure 3).32
Analysis of the cell lysates by NMR and size-exclusion
chromatography revealed that these unfolded species are not
oligomeric and are irreversibly formed, i.e., they cannot bind
zinc even when zinc is supplemented after cell lysis. In vitro, the
same mutant proteins are fully capable of binding zinc and
exhibit a WT-like conformation both in the apo state and the
zinc-bound state (Figure 3c), indicating that in the cell an
irreversible unfolding/misfolding event had occurred prior to
metal binding. These findings are consistent with a pathway of
SOD1 misfolding and aggregation that starts from the apo
reduced state, which is destabilized in vitro by fALS-linked
mutations.33 The unfolded species observed by NMR are
therefore likely the precursors of aggregates, which have not yet
formed because of the short experimental time (48 h of protein
expression prior to NMR observation). Remarkably, coex-
pression of CCS together with mutant SOD1 restored the
correct maturation pathway, causing a drastic decrease in the
amount of unfolded species and the appearance of the signals of
the correctly folded SOD1.32 This effect of CCS, which is
reportedly involved in the last steps of SOD1 maturation
(copper binding and disulfide bond formation), prompted us to
further investigate its role in the early steps (i.e., folding and
zinc binding) of mutant SOD1 maturation. CCS consists of two
globular domains: the N-terminal Atx1-like domain D1, which
is responsible for copper(I) delivery, and the SOD-like domain
D2, which forms a heterodimer with immature SOD1.34 At the
C-terminus, a disordered sequence (D3) catalyzes the
formation of the SOD1 disulfide bond through a thiol−
disulfide exchange mechanism, likely coupled to the copper(I)
transfer.35 We isolated the SOD1 recognition function of CCS
by coexpressing only the second domain of CCS (D2) with the
WT SOD1 and the fALS-linked mutants.36 As expected, the
CCS-dependent maturation does not occur without D1 and
D3, and the SOD1−D2 heterodimer becomes a stable
intermediate in the cell. Importantly, D2 in the cell acts as a
molecular chaperone toward the destabilized SOD1 mutants.
Indeed, D2 is able to interact with the apo form of SOD1, and
Figure 3. fALS-linked SOD1 mutations cause intracellular SOD1
unfolding and impaired zinc binding. (a, b) 1H−15N in-cell NMR
spectra of the SOD1 mutants (a) G93A and (b) I113T (blue), both
present as unfolded apo species even with zinc in excess. (c) 1H−15N
in vitro NMR spectra of apo-I113T SOD1 (black spectrum) and Zn-
I113T SOD1 (red spectrum) showing folded, WT-like conformations.
Adapted with permission from ref 32. Copyright 2014 Springer
Nature.
Accounts of Chemical Research Article
DOI: 10.1021/acs.accounts.8b00147
Acc. Chem. Res. XXXX, XXX, XXX−XXX
D
in doing so it stabilizes its fold and allows zinc binding, thereby
preventing the irreversible misfolding of mutant SOD1. Such a
novel molecular chaperone role of D2 highlights the
importance of CCS in rescuing the correct folding of SOD1
and suggests future therapeutic strategies that potentiate this
mechanism in fALS patients.
Protein Redox States and Regulation
As shown above, in-cell NMR can directly assess conforma-
tional changes caused by intracellular events such as metal
binding and the formation of disulfide bonds. The function of
many intracellular proteins is modulated by disulfide bond
formation, which is regulated within different cellular compart-
ments by specific redox partners. In-cell NMR can therefore
provide unique insights into intracellular protein redox
regulation at the molecular level thanks to the ability of
NMR to identify directly the conformation of each redox state
and to determine changes in the redox distribution as a
function of intracellular partners or external stimuli. In this
respect, direct protein expression is ideally suited for studying
redox-sensitive proteins, which could be prone to artifacts if
delivered from outside the cell. We first showed that the redox
state of the mitochondrial protein Mia40 in the cytosol is
regulated by the redox-regulating enzymes glutaredoxin 1
(Grx1) and thioredoxin (Trx).21 Mia40 is a redox chaperone of
the IMS of mitochondria that is constituted by a coiled-coil
helix, coiled-coil helix (CHCH) domain stabilized by two
structural disulfide bonds.37 In the IMS, Mia40 catalyzes the
oxidative folding of other small mitochondrial proteins that
harbor the same CHCH domain.38 Like its substrates, Mia40 is
synthesized in the cytosol and has to be imported into the
mitochondria in the reduced, unfolded state. However,
increased levels of Mia40 accumulate in the cytosol and are
found mostly in the oxidized, folded state that is not import-
competent. Coexpression of the thiol−disulfide-regulating
proteins Grx1 and Trx shifts the redox distribution of cytosolic
Mia40 toward the reduced state, indicating that proteins may
not reach redox equilibrium with the environment unless the
correct redox partners are present at sufficient levels. We
further investigated the relationship between the redox
properties of the environment and the redox state of cytosolic
proteins by in-cell NMR. The redox distribution of SOD1 and
Cox17a substrate of Mia40was also analyzed in the cytosol
of human cells (HEK293T), Escherichia coli (BL21), and a less
reducing strain of E. coli (Origami B), which have different
redox potentials as defined by the glutathione−glutathione
disulfide couple.39 Notably, the observed redox distribution
clearly deviates from what would be expected at the redox
equilibrium in each cellular environment. In human cells,
coexpression of the known intracellular redox partners (Grx1/
Trx for Mia40 and Cox17, CCS for SOD1) changes the redox
distribution, either toward the equilibrium with glutathione (in
the case of Mia40 and Cox17, Figure 4) or further away from it
(in the case of SOD1). These findings support the notion that
the redox state of most intracellular proteins is uncoupled from
that of the glutathione pool and consequently that protein
redox regulation needs to be kinetically controlled by specific
partners, similar to how other post-translational modifications
are regulated. Further evidence for kinetic control of the
intracellular redox state was provided for the thioredoxin−
thioredoxin reductase couple.40
While under basal conditions the redox states of intracellular
proteins are regulated by specific partners, they can dramatically
change in response to external stimuli. In living organisms, an
imbalance between the cellular production of reactive oxygen
species and the antioxidant defense of the cell causes oxidative
stress, which is involved in a plethora of physiological and
pathological states, including aging, diabetes, and most
degenerative diseases.41 At the molecular level, oxidative stress
affects the redox states of many intracellular proteins, and in-
cell NMR is the ideal methodology to observe such changes.
We recently characterized the intracellular metal binding and
redox state of DJ-1 under basal and stress conditions. DJ-1
(PARK7) is a ubiquitous protein involved in the cellular
response against oxidative stress.42 DJ-1 has been associated
with several pathologies, including cancer, Parkinson’s disease,
ALS, and ischemic injury. Despite the many roles attributed to
DJ-1, ranging from proteasome regulation to chaperone and
enzymatic activity, its precise function is not yet clear.43 A
redox-sensitive cysteine (C106) lies in the putative active site of
the protein, for which different oxidation states have been
Figure 4. Protein redox state distribution monitored by in-cell NMR. (a−c) 1H−15N in-cell NMR spectra of intracellular [15N]cysteine-labeled
Cox17 (a) without and (b) with coexpressed Grx1 and (c) [15N]cysteine-labeled DJ-1 in control cells (black) and in cells treated with H2O2
(magenta). (d−f) Schematic illustrations of (d, e) thiol−disulfide regulation of Cox17 and (f) oxidation of DJ-1 C106 to sulfinic acid. Adapted with
permission from (a, b) ref 39 and (c) ref 44. Copyright 2016 Elsevier and 2018 Springer Nature, respectively.
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reported both in vitro and in vivo. C106 has been proposed to
act as a ROS sensor, and its oxidation causes the loss of several
functions of DJ-1. DJ-1 has also been reported to bind zinc and
copper ions in its active site in vitro. The conformation of
intracellular DJ-1 in differently treated cells was analyzed by
comparing in-cell and in vitro NMR data in order to clarify the
physiological state of the protein under basal and cell stress
conditions.44 In cells, no metal binding to DJ-1 occurred under
any experimental conditions, consistent with the affinity of DJ-1
for zinc or copper being too low to compete against the metal
buffering systems of the cell, whereas oxidative stress induced
by H2O2 treatment caused the quantitative oxidation of the
C106 thiol (−SH) to sulfinic acid (−SO2H) (Figure 4c). No
other previously reported oxidation states (i.e., sulfenic acid
(−SOH) and sulfonic acid (−SO3H)) were observed, as
confirmed also by mass spectrometry, suggesting that in vivo
DJ-1 may act as a redox sensor that switches between the C106
−SH and −SO2H states.
■ FUTURE PERSPECTIVES
The applications described above show that protein expression
in human cells can be successfully applied to investigate
functional processes involving intracellular soluble proteins by
solution NMR. Each specific case highlights the various types of
structural perturbations that can be investigated: changes in the
folding state (in the case of SOD1 and its mutants), thiol−
disulfide redox regulation (SOD1, Mia40, and Cox17), metal
binding (SOD1 and DJ-1), and response to oxidative stress
(DJ-1). In all instances, the major strength of in-cell NMR is
the ability to provide biologically meaningful structural
information in the native cellular environment, which is then
complemented by thorough in vitro NMR characterization of
the various conformations. Overall, the in-cell NMR method-
ology has seen steady development in the last two decades,
spanning several model organisms. In human cells, as an
alternative to protein expression, insertion approaches have
been successfully applied to study the effects of crowding on
protein folding and conformation,8 post-translational modifica-
tions,45 redox state,40 and interactions with other cellular
partners.9 Labeling tools have been developed, such as fluorine-
containing amino acids to probe protein dynamics by in-cell 19F
NMR46 and lanthanide-based tags that can provide long-range
spatial restraints by paramagnetic in-cell NMR.47,48 Further-
more, proteins in native membranes can be investigated by
solid-state NMR49 thanks to the sensitivity boost provided by
dynamic nuclear polarization. In the near future, continuous
technological developments will further increase the applic-
ability of NMR to human cells. Progress in NMR hardware has
constantly decreased the minimum protein concentration
required. The development of bioreactors for high-field NMR
spectrometers50,51 will increase the sample lifetime, allowing
longer experimental times and, notably, continuous measure-
ment of time-dependent processes. Finally, future approaches
relying on protein expression will benefit from advanced tools
for genome engineering, such as transposon-based systems,52
and finer control of the expression of two or more proteins with
the use of inducible promoters. We believe that in-cell NMR
will continue to be a powerful method to identify the true
physiological states (versus the many possible nonphysiological
states obtainable in vitro), acting as a guide to the in vitro
analysis, and that it will be further integrated with other
emerging cellular and structural techniques.53−55
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